Doolittle D J, Rahn C A, Lee C K
Cellular and Molecular Biology Division, R.J. Reynolds Tobacco Company, Winston-Salem, NC 27102.
Mutat Res. 1991 May;260(1):9-18. doi: 10.1016/0165-1218(91)90075-w.
Cigarette smokers have been reported to void urine which is more mutagenic than that voided by non-smokers, but the specific urinary mutagen(s) have not been identified. Since mechanistic studies are best performed in animal models, the objective of this study was to determine if a model to study the role of cigarette smoke and its components in urinary mutagenicity could be developed in rats. XAD-2 resin was used to concentrate the urine and the microsuspension modification of the Ames test used to quantify mutagenicity. Nicotine administered by intraperitoneal injection at 0.8 mg/kg (the maximum tolerated dose) or inhalation of carbon monoxide for 14 days at the maximum tolerated dose (1800 ppm, resulting in 68% carboxyhemoglobin) did not increase urinary mutagenicity. Cigarette smoke condensate (CSC) prepared by electrostatic precipitation of mainstream smoke increased urinary mutagenicity at doses of 100 and 200 mg/kg when administered acutely by either i.p. injection or gavage, verifying that the assay system was capable of detecting cigarette smoke-related mutagens in the urine. However, cigarette smoke administered by the appropriate route of exposure, nose-only inhalation, for 1, 7, 14 or 90 days (1 h per day) did not increase urinary mutagenicity. The smoke concentration administered was at or near the maximum tolerated dose as evidenced by carboxyhemoglobin concentrations of approximately 50%, and of 10% or more weight loss in exposed animals. Thus, although cigarette smoke condensate is mutagenic in vitro and mutagenic urine was observed when rats were given high doses of CSC by inappropriate routes of administration, acute or subchronic inhalation exposure to the maximum tolerated dose of whole cigarette smoke did not increase urinary mutagenicity in rats. These results indicate that the rat may be an inappropriate model to study urinary mutagenicity following the inhalation of tobacco smoke.
据报道,吸烟者排出的尿液比不吸烟者排出的尿液具有更强的致突变性,但具体的尿液诱变剂尚未确定。由于机制研究最好在动物模型中进行,本研究的目的是确定是否可以在大鼠中建立一个模型来研究香烟烟雾及其成分在尿液致突变性中的作用。使用XAD - 2树脂浓缩尿液,并使用Ames试验的微悬浮改良法来量化致突变性。以0.8mg/kg(最大耐受剂量)腹腔注射尼古丁或在最大耐受剂量(1800ppm,导致68%的羧基血红蛋白)下吸入一氧化碳14天,均未增加尿液的致突变性。通过静电沉淀主流烟雾制备的香烟烟雾冷凝物(CSC),以100mg/kg和200mg/kg的剂量经腹腔注射或灌胃急性给药时,会增加尿液的致突变性,这证实了该检测系统能够检测尿液中与香烟烟雾相关的诱变剂。然而,通过适当的暴露途径——仅经鼻吸入——给予香烟烟雾1、7、14或90天(每天1小时),并未增加尿液的致突变性。所给予的烟雾浓度处于或接近最大耐受剂量,这可从羧基血红蛋白浓度约为50%以及暴露动物体重减轻10%或更多得到证明。因此,尽管香烟烟雾冷凝物在体外具有致突变性,并且当以不适当的给药途径给大鼠高剂量的CSC时观察到尿液具有致突变性,但急性或亚慢性吸入最大耐受剂量的完整香烟烟雾并未增加大鼠尿液的致突变性。这些结果表明,大鼠可能不是研究吸入烟草烟雾后尿液致突变性的合适模型。